Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Pediatrics/Neonatology  |  Vaccines

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Vaccines Clinical Trials

A listing of Vaccines medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (12) clinical trials

A Research Study of an Investigational Cytomegalovirus (CMV) Vaccine


Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.


Pertussis Immunization During Pregnancy & HIV Infection

Despite the growing importance of maternal immunization in the control of infectious pathogens in early life, the impact of pregnancy on vaccine immunogenicity remains poorly understood. Evidence suggests that pregnancy may influence the quality of the antibody response to vaccines. Pregnancy is associated with modifications in the glycosylation profile of ...

Phase N/A

Safety and Immunogenicity Study of DNA.HTI and MVA.HTI in HIV-1-positive Patients(AELIX-002)

AELIX Therapeutics in collaboration with IrsiCaixa has developed a novel immunogen, termed HTI which was designed as an immunogen for T cells to be used as a a therapeutic HIV vaccine that could help HIV infected individuals to control viral replication in the absence of antiretroviral treatment. HTI is a ...


Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation

People living with HIV (PLWH) have an increased risk of cardiovascular disease (CVD) compared to individuals without HIV. Increased systemic immune activation and arterial inflammation are thought to contribute to this increased risk by affecting the highly inflammatory process of atherosclerotic plaque formation and progression. This study will evaluate whether ...

Phase N/A

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

Study Design: This is a prospective cohort study. Population: Target groups for vaccination defined by The National Immunization Program of Brazil: healthcare workers and elderly (people over 60 years old). Study Size: A total of 400 individuals (150 health care workers and 250 elderly), presenting for immunization with IB TIV, ...

Phase N/A

A Pragmatic Trial of An Adaptive eHealth HIV Prevention Program for Diverse Adolescent MSM

Adolescent (ages 13-18) men who have sex with men (AMSM) experience a dramatic health disparity as they represent 2% of young people but account for almost 80% of HIV diagnoses in youth. Despite this disproportionate burden, current evidence-based HIV prevention programs focus primarily on adults and heterosexual youth. Because issues ...

Phase N/A

BARDA Securing Anthrax Immunity For the Elderly

This is a phase 2, randomized, active-controlled, double-blinded, multi-site study to assess the safety and immunogenicity of BioThrax (Anthrax Vaccine Adsorbed) and AV7909 (Anthrax Vaccine Adsorbed plus CPG 7909 adjuvant) using a post-exposure prophylaxis dosing regimen in adults 66 years of age in stable health. The safety and immunogenicity profile ...


Effect of ERIG Injection on Day 7 After First Dose of Rabies Vaccination to Rabies Immune Response

Rabies immunoglobulin (RIG) should be administered as soon as possible after the initiation of post-exposure prophylaxis. RIG should not be given after day 7 following the first rabies vaccine dose, because circulating neutralizing antibody will have begun to appear. Nevertheless, no study was conducted to evaluate the rabies neutralizing antibody ...

Phase N/A

Study of Safety Tolerability and Immunogenicity of Gardasil 9 in Immunocompromised Patients

This is a single-center, open-label study on safety, tolerability and immunogenicity of Gardasil9 in 18 to 45 year-old HIV patients, in 18 to 55 year-old solid-organ transplant (SOT) patients. This study will enrol 140 HIV patients with CD4+ (cluster of differentiation 4) count of >200cells/mm and 170 SOT patients, all ...